• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 ANTI-TG AB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED IMMULITE 2000 ANTI-TG AB Back to Search Results
Model Number IMMULITE 2000 ANTI-TG AB
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/07/2017
Event Type  malfunction  
Manufacturer Narrative
A siemens customer service engineer (cse) was dispatched to the customer site.The cse determined that the calibration for kit lot 673 and quality control for lot 026 were within acceptable range.The cse installed a new kit lot # 674 as he suspected the problem with reagent.Calibration and quality control were rerun, which were acceptable.The cse installed the fresh sample diluent for anti-tg ab.The issue still persisted.The same sample diluent was used to run antithyroid peroxidase antibody testing and the results were acceptable.The cse performed decontamination procedure and ran water test, which was acceptable.A siemens headquarters support center (hsc) specialist reviewed the event data and stated that siemens has no correlation claims between advia centaur and immulite 2000 anti-tg ab methods.Because of the differences in assay architectures, assay antibodies/antigens and assay standardizations, differences like these may be seen between the two assays.As stated in the immulite 2000 anti-tg ab instructions for use, "the results obtained from this assay should always be used in combination with the clinical examination, patient medical history, and other findings".Clinically discordant results are not uncommon among anti-tg assays.The assay measures antibodies and antibodies are not unique molecular entities, but rather mixtures of immunoglobulins that only have in common their ability to interact with tg, and this heterogeneity in anti-tg is the potential cause of discordance seen in patient samples.The cause of the discordant anti-tg ab results on patient samples is unknown.
 
Event Description
Discordant autoantibodies to thyroglobulin (anti-tg ab) results were obtained on patient samples when comparing the results between immulite 2000 xpi and advia centaur xpt instruments.The results from immulite 2000 xpi instrument were not reported to the physician(s).The results from the advia centaur xpt instrument were reported to the physician(s).There are no reports of patient intervention or adverse health consequences due to the discordant anti-tg ab results.
 
Manufacturer Narrative
The initial mdr 2432235-2018-00033 was filed on 29-jan-2018.Additional information (26-mar-2018): based on the additional information received on 08-mar-2018, mdr 2432235-2018-00127 was filed for the same issue.
 
Manufacturer Narrative
The initial mdr 2432235-2018-00033 was filed on 29-jan-2018.The first supplemental mdr 2432235-2018-00033_s1 was filed on 26-mar-2018.Additional information (13-apr-2018): the customer provided patient samples for in-house testing.Siemens tsl ran 14 patient samples on an immulite 2000 instrument using kit lots 672 and 673 and on the advia centaur instrument using kit lot 298.Two samples could not be retested on the advia centaur instrument due to insufficient sample quantity.For the remaining samples, 9 of 12 samples were clinically concordant.A siemens headquarters support center specialist reviewed the event details and determined that the assays on the advia centaur and immulite 2000 xpi have different cut-offs, use different antigens and antibodies, and use different architectures.Most antibody assays have poor correlation to each other.The cause of the discordant anti-tg ab results on patient samples is unknown.Method code has been updated in section h6.No further evaluation of device is required.Mdr 2432235-2018-00127_s1 was filed for the same event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMMULITE 2000 ANTI-TG AB
Type of Device
IMMULITE 2000 ANTI-TG AB
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS, LIMITED
glyn rhonwy
llanberis
gwynedd, LL55 4EL
UK  LL55 4EL
MDR Report Key7226121
MDR Text Key98740292
Report Number2432235-2018-00033
Device Sequence Number1
Product Code JZO
UDI-Device Identifier00630414962108
UDI-Public00630414962108
Combination Product (y/n)N
PMA/PMN Number
K991094
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 05/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/29/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberIMMULITE 2000 ANTI-TG AB
Device Lot Number673
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received04/13/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-